Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-22
2008-04-22
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S333000, C546S270100, C546S256000
Reexamination Certificate
active
10295414
ABSTRACT:
Disclosed are substituted heteroarylalkanoic acids acids of the following formula D-A-C(O)R′, where D, A, and R′ are defined herein. These compounds are useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their synthesis.
REFERENCES:
patent: 5990314 (1999-11-01), Daines
patent: WO 9322285 (1993-11-01), None
patent: WO 0123383 (2001-04-01), None
Mylari BL et al. J. Med. Chem. (1992) 35, 457-465.
Geraci Leo
Van Zandt Michael C.
McDonnell Boehnen & Hulbert & Berghoff LLP
Morris Patricia L.
The Institute for Pharmaceutical Discovery, Inc.
LandOfFree
Substituted heteroarylalkanoic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heteroarylalkanoic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heteroarylalkanoic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3940351